Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A genome wide scan for early onset primary hypertension in Scandinavians.
von Wowern F, Bengtsson K, Lindgren CM, Orho-Melander M, Fyhrquist F, Lindblad U, Råstam L, Forsblom C, Kanninen T, Almgren P, Burri P, Katzman P, Groop L, Hulthén UL, Melander O. von Wowern F, et al. Among authors: fyhrquist f. Hum Mol Genet. 2003 Aug 15;12(16):2077-81. doi: 10.1093/hmg/ddg206. Hum Mol Genet. 2003. PMID: 12913078
The effect of dexamethasone on the enteroinsular axis.
Groop PH, Groop LC, Tötterman KJ, Fyhrquist F. Groop PH, et al. Among authors: fyhrquist f. Scand J Clin Lab Invest. 1987 Sep;47(5):491-5. Scand J Clin Lab Invest. 1987. PMID: 3310195
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S; LIFE Study Group. Lindholm LH, et al. Among authors: fyhrquist f. Lancet. 2002 Mar 23;359(9311):1004-10. doi: 10.1016/S0140-6736(02)08090-X. Lancet. 2002. PMID: 11937179 Clinical Trial.
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group. Lindholm LH, et al. Among authors: fyhrquist f. J Hypertens. 2002 Sep;20(9):1879-86. doi: 10.1097/00004872-200209000-00035. J Hypertens. 2002. PMID: 12195132 Clinical Trial.
Do sulfonylureas influence hepatic insulin clearance?
Groop LC, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A. Groop LC, et al. Among authors: fyhrquist f. Diabetes Care. 1988 Sep;11(8):689-90. doi: 10.2337/diacare.11.8.689. Diabetes Care. 1988. PMID: 3065007 No abstract available.
346 results